Percutaneous ventricular assist device placement during active cardiopulmonary resuscitation for severe refractory cardiogenic shock after acute myocardial infarction
- PMID: 17622370
- PMCID: PMC1894693
Percutaneous ventricular assist device placement during active cardiopulmonary resuscitation for severe refractory cardiogenic shock after acute myocardial infarction
Abstract
Cardiogenic shock after acute myocardial infarction is associated with a high mortality rate despite modern reperfusion methods and intra-aortic balloon pump support. For myocardial infarction patients in cardiogenic shock that is refractory to intra-aortic ballon pump counterpulsation and pressors (severe refractory cardiogenic shock), there are limited means to rapidly provide additional hemodynamic support. We present the case of a 49-year-old man who presented with an anterior wall acute myocardial infarction complicated by cardiogenic shock. After resuscitation and stabilization with intra-aortic balloon pump and pressor support, the patient underwent successful emergent percutaneous transluminal coronary angioplasty and stenting of the left anterior descending coronary artery. Forty-eight hours later, the patient again went into severe refractory cardiogenic shock; pulseless electrical activity arrest followed. Cardiopulmonary resuscitation was started, and the patient underwent urgent placement of a TandemHeart percutaneous ventricular assist device. The device enabled the reversal of terminal hemodynamic collapse during active cardiopulmonary resuscitation, subsequent stabilization of the patient, and discharge of the patient from the hospital after device removal. In this patient, the percutaneous ventricular assist device was successful in the treatment of severe refractory cardiogenic shock after acute myocardial infarction.
Figures

Similar articles
-
Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction.Catheter Cardiovasc Interv. 2006 Aug;68(2):263-6. doi: 10.1002/ccd.20846. Catheter Cardiovasc Interv. 2006. PMID: 16819772
-
[Percutaneous insertion of a left ventricular assist device for cardiogenic shock in a patient with a myocardial infarction].Ned Tijdschr Geneeskd. 2003 Jan 25;147(4):164-6. Ned Tijdschr Geneeskd. 2003. PMID: 12635549 Dutch.
-
Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.J Heart Lung Transplant. 2008 Jan;27(1):106-11. doi: 10.1016/j.healun.2007.10.013. J Heart Lung Transplant. 2008. PMID: 18187095
-
[Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].Herz. 1999 Oct;24(6):448-64. doi: 10.1007/BF03044431. Herz. 1999. PMID: 10546149 Review. German.
-
Cardiogenic shock complicating myocardial infarction and outcome following percutaneous coronary intervention.Acute Card Care. 2008;10(3):131-43. doi: 10.1080/17482940801983006. Acute Card Care. 2008. PMID: 18972627 Review.
Cited by
-
Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions.Curr Cardiol Rep. 2009 Sep;11(5):369-76. doi: 10.1007/s11886-009-0051-7. Curr Cardiol Rep. 2009. PMID: 19709497 Review.
-
Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrest.Int J Angiol. 2012 Sep;21(3):163-6. doi: 10.1055/s-0032-1324736. Int J Angiol. 2012. PMID: 23997562 Free PMC article.
-
Percutaneous ventricular assist devices: new deus ex machina?Minim Invasive Surg. 2011;2011:604397. doi: 10.1155/2011/604397. Epub 2011 Jul 31. Minim Invasive Surg. 2011. PMID: 22091361 Free PMC article.
-
Percutaneous ventricular assist devices for cardiogenic shock.Curr Heart Fail Rep. 2008 Sep;5(3):163-9. doi: 10.1007/s11897-008-0025-x. Curr Heart Fail Rep. 2008. PMID: 18752766 Review.
References
-
- Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162–8. - PubMed
-
- Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995;26:668–74. - PubMed
-
- Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005;294:448–54. - PubMed
-
- Holmes DR Jr, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999;100:2067–73. - PubMed
-
- Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, Parker C, Braunwald E. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989;14:40–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical